Identifying either T2D patients, irrespective of BMI, or obese patients, without diabetes, who are at imminent risk of a fragility fracture is rather difficult because of the dearth in knowledge about how the interactions among diet, obesity, and insulin insensitivity affect bone. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.